Search results
1 kwi 2022 · Heart failure remains a leading cause of morbidity and mortality globally. The 2022 heart failure guideline provides recommendations based on contemporary evidence for the treatment of these patients.
- Circulation
National Center. 7272 Greenville Ave.Dallas, TX 75231....
- E F Cook
Evaluation of the Functional Reserve and Exercise Tolerance...
- Figure 1
Background: Diagnosis of heart failure with preserved...
- Cardiac Amyloidosis
Transthyretin amyloid cardiomyopathy (ATTR-CM) results in a...
- 2010 Accf/Aha Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults
Markers reflective of autonomic nervous system function can...
- 2021 Acc/Aha/Scai Guideline for Coronary Artery Revascularization
The strongest evidence in the past decade to support...
- Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies
Hydroxychloroquine is a common therapy for patients with...
- Contemporary Reevaluation of Race and Ethnicity With Outcomes in Heart Failure
The public health burden of chronic heart failure (HF) is...
- Circulation
The therapy recommendations mention the treatment effect supported by the class and level of evidence and are presented in tables. In this guideline, we have decided to focus on the diagnosis and treatment of HF, not on its prevention. The 2023 Focused Update of these Guidelines is available here.
The 2021 guideline marks a significant change in HF management. It advises that once diagnosed, patients with HF and a reduced ejection fraction (HeFREF) should be treated with two renin-
17 wrz 2022 · Splanchnic nerve modulation has been proven beneficial for both acute decompensated (ADHF) and chronic heart failure (CHF), according to the Splanchnic Nerve Anesthesia in Heart Failure and Abdominal Nerve Blockade in Chronic Heart Failure trials.
27 sie 2021 · Recommendations for the treatment of patients with heart failure with preserved ejection fraction窶や ・632. Recommendations for the primary prevention of heart failure in patients with risk factors for its development窶や ・632. Multidisciplinary interventions recommended for the management of chronic heart failure窶や ・633.
1 kwi 2022 · TOP 10 TAKE-HOME MESSAGES. Guideline-directed medical therapy (GDMT) for heart failure (HF) with reduced ejection fraction (HFrEF) now includes 4 medication classes that include sodium-glucose cotransporter-2 inhibitors (SGLT2i).
A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart Failure (trial) COMPASS.
